Abigael Rae Dollens, PA

Abigael Dollens practices at Healthtexas Provider Network in Dallas, Texas.

Abigael Dollens' NPI, 1023721289, was assigned on January 3, 2023.

Abigael Dollens' primary practice is Healthtexas Provider Network, at 301 N Washington Ave, Dallas, TX 75246 in Dallas County. The practice phone is (214) 820-3466.

Abigael Dollens' primary practice is Healthtexas Provider Network in Dallas, Texas. Abigael Dollens is also affiliated with Baylor University Medical Center. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Abigael Dollens to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Abigael Dollens practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Abigael Dollens' primary specialty in the NPI Registry, under taxonomy code 363A00000X.

CMS data shows 62 Medicare services from Abigael Dollens across 2 procedure codes in 2024, for 43 Medicare patients. Medicare paid $2,714 for them. Every service was in an office.

CMS counts 43 Medicare patients who saw Abigael Dollens in 2024. The largest group is 65 to 74, with 27 patients. 74% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Abigael Dollens' median patient age at 37, with 72% women.

In 2024, Abigael Dollens wrote 825 Medicare Part D claims for 200 patients. 87% of them were for generic drugs. CMS names the drug for 476 of them, across 21 drugs with 11 or more claims each, at $22,608 in total drug cost.

Abigael Dollens accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Abigael Dollens as offering telehealth.

CMS Open Payments shows 134 general payments to Abigael Dollens from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $523.